Atlas Trials

Stero Biotechs Ltd.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Stero Biotechs Ltd.

RecordFirmDate
Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients (NCT04439955)Stero Biotechs Ltd.2020-02-01
A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients (NCT04056442)Stero Biotechs Ltd.2019-07-07
A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis (NCT04129489)Stero Biotechs Ltd.2019-02-07

Track Stero Biotechs Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.